Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Beatriz M. Awni"'
Autor:
Camila B. Xavier, Carlos Diego H. Lopes, Beatriz M. Awni, Eduardo F. Campos, João Pedro B. Alves, Anamaria A. Camargo, Gabriela D. A. Guardia, Pedro A. F. Galante, Denis L. Jardim
Publikováno v:
Cancers. 14(21)
Purpose: Solid tumors harboring tumor mutational burden (TMB) ≥10 mutations per megabase (mut/Mb) received agnostic approval for pembrolizumab. This work aims to analyze the somatic mutational profile’s influence on the outcomes of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e9c9d500ded73908c7eebaefa54915
https://pubmed.ncbi.nlm.nih.gov/36358851
https://pubmed.ncbi.nlm.nih.gov/36358851
Autor:
Camila B. Xavier, Carlos Diego H. Lopes, Beatriz M. Awni, Eduardo F. Campos, João Pedro B. Alves, Anamaria A. Camargo, Gabriela D. A. Guardia, Pedro A. F. Galante, Denis L. Jardim
PurposeSolid tumors harboring tumor mutational burden (TMB) ≥ 10 mutations per megabase (mut/Mb) received agnostic approval for pembrolizumab. However, TMB cut-off alone is not a predictor of overall survival (OS). This work aims to analyze the som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c973dd1f91ebe2ace6e9c061dab20369
https://doi.org/10.1101/2022.04.10.22273664
https://doi.org/10.1101/2022.04.10.22273664
